Back

Bone marrow mesenchymal stromal cells mediate cellular inflammation in HFpEF

Mentkowski, K.; Lee, I.-H.; Rohde, D.; Paccalet, A.; Seung, H.; Kumowski, N.; Schloss, M. J.; Carpenito-Kronenfeld, M.; Kaushal, V.; Jain, R.; Memcaj, X.; Wiebe, J.; Momin, N.; Pabel, S.; Muse, C. G.; Tuy, K.; Ung, S.; Roh, J.; Swirski, F. K.; Scadden, D.; van Galen, P.; Kreso, A.; Naxerova, K. N.; Hulsmans, M.; Nahrendorf, M.

2025-04-02 immunology
10.1101/2025.03.28.645924 bioRxiv
Show abstract

During the genesis of heart failure, the myocardium recruits an abundance of bone marrow-derived leukocytes, primarily monocytes, with various disease-promoting functions. Increased hematopoiesis fuels these unfavorable changes in cardiac leukocyte origin, number and phenotype. Here we examine hematopoietic niche cells, which regulate blood progenitor proliferation and systemic monocyte supply, in obese, hypertensive mice that develop heart failure with preserved ejection fraction (HFpEF). Single cell transcriptomics revealed that in HFpEF, stromal bone marrow niche cells expand and respond strongly to IFN{gamma}. Deleting the IFN{gamma} receptor in stromal cells of Prrx1CreERT2;Ifngr1fl/fl mice reduced hematopoietic progenitor proliferation and systemic monocytes in both the steady state and HFpEF and also increased the canonical hematopoietic maintenance factor CXCL12, resulting in reduced fibrosis and improved diastolic function. CD8+ T cells in adipose tissue were a major source of IFN{gamma} in mice with HFpEF; their depletion restored CXCL12 expression and lowered monocyte numbers. ScRNA-seq in mice with ischemic heart disease uncovered a diverging marrow response. These data indicate that in HFpEF, adipose tissue, bone marrow and adaptive and innate immune cells conspire to expand harmful macrophage subsets in the heart.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Circulation Research
39 papers in training set
Top 0.1%
16.9%
2
Circulation
66 papers in training set
Top 0.2%
14.2%
3
Nature Cardiovascular Research
28 papers in training set
Top 0.1%
11.9%
4
Journal of Experimental Medicine
106 papers in training set
Top 0.7%
4.0%
5
Science
429 papers in training set
Top 8%
3.8%
50% of probability mass above
6
Science Translational Medicine
111 papers in training set
Top 1%
3.5%
7
Nature
575 papers in training set
Top 7%
3.5%
8
Cell
370 papers in training set
Top 7%
3.5%
9
Nature Immunology
71 papers in training set
Top 0.8%
3.0%
10
Cell Reports
1338 papers in training set
Top 18%
2.8%
11
JCI Insight
241 papers in training set
Top 2%
2.8%
12
eLife
5422 papers in training set
Top 31%
2.8%
13
Nature Communications
4913 papers in training set
Top 45%
2.5%
14
Journal of Clinical Investigation
164 papers in training set
Top 2%
2.5%
15
Immunity
58 papers in training set
Top 2%
2.0%
16
Cardiovascular Research
33 papers in training set
Top 0.5%
1.6%
17
PLOS Biology
408 papers in training set
Top 14%
1.2%
18
Nature Metabolism
56 papers in training set
Top 2%
0.9%
19
EMBO Molecular Medicine
85 papers in training set
Top 3%
0.9%
20
Cancer Discovery
61 papers in training set
Top 2%
0.9%
21
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 2%
0.9%
22
Cell Metabolism
49 papers in training set
Top 2%
0.8%
23
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 45%
0.7%
24
Cell Reports Medicine
140 papers in training set
Top 8%
0.7%
25
Science Advances
1098 papers in training set
Top 32%
0.7%